A COMPREHENSIVE REVIEW OF RADIOTHERAPY AND CHEMOTHERAPY-INDUCED MORPHOLOGICAL SIDE EFFECTS IN BREAST CANCER TREATMENT: STRATEGIES FOR MANAGEMENT AND MITIGATION

Kholmatov Sh.O.; Madaminov S.M.; Zokirjonov D.Z.; Sobirova D.R.

doi:10.5281/zenodo.11552469

A COMPREHENSIVE REVIEW OF RADIOTHERAPY AND CHEMOTHERAPY-INDUCED MORPHOLOGICAL SIDE EFFECTS IN BREAST CANCER TREATMENT: STRATEGIES FOR MANAGEMENT AND MITIGATION

10.06.2024 International Scientific Journal "Science and Innovation". Series D. Volume 3 Issue 6

Kholmatov Sh.O., Madaminov S.M., Zokirjonov D.Z., Sobirova D.R.

Abstract. Breast cancer is one of the most prevalent malignancies affecting women globally. The primary treatment options for breast cancer include surgery, radiotherapy, chemotherapy, or a combination of these modalities. While these treatments have significantly improved survival rates and disease management, they are not without complications and side effects. These adverse effects can substantially impact a patient’s quality of life and overall treatment experience. This paper aims to comprehensively review the common problems associated with radiotherapy and chemotherapy in breast cancer patients, drawing on current research to provide a detailed analysis of these issues and their management strategies

Keywords: breast cancer, radiotherapy, chemotherapy, side effects, quality of life, skin reactions, cardiovascular toxicity, lung toxicity, lymphedema, secondary cancers, hematologic toxicity, cardiotoxicity, neurotoxicity, cognitive dysfunction, alopecia, pain management, antiemetic regimens, growth factors, supportive care, personalized treatment

References:

1. Belkacemi, Y., et al. (2018). Radiation Dermatitis in Breast Cancer: Prevention and Management. Breast Journal, 24(3), 278-284. 2. Haviland, J. S., et al. (2010). Evaluation of Late Adverse Effects of Radiotherapy for Breast Cancer: The IMPORT Trial. Lancet Oncology, 11(3), 231-240. 3. Luo, C., et al. (2019). Pain Management in Breast Cancer: Current Practice and Future Directions. Journal of Pain and Symptom Management, 57(4), 771-781. 4. Mejdahl, M. K., et al. (2013). Persistent Pain and Sensory Disturbances in Breast Cancer Survivors. Journal of the National Cancer Institute, 105(1), 59-64. 5. Darby, S. C., et al. (2013). Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer. New England Journal of Medicine, 368(11), 987-998. 6. Gagliardi, G., et al. (2010). Radiation-Induced Lung Damage: Predicting Functional Consequences and Defining Tolerances. Clinical Oncology, 22(2), 111-122. 7. Shah, C., et al. (2012). Breast Cancer-Related Lymphedema: A Review of Incidence, Risk Factors, and Treatment. Journal of Clinical Oncology, 30(35), 4280-4286. 8. Berrington de González, A., et al. (2010). Second Cancers After Radiotherapy for Breast Cancer in SEER Cancer Registries. British Journal of Cancer, 102(1), 220-226. 9. Hesketh, P. J., et al. (2016). The Management of Nausea and Vomiting in Cancer Patients. Cancer Journal, 22(2), 104-109. 10. Andreyev, H. J., et al. (2014). Gastrointestinal Symptoms in Patients with Cancer: The Role of the Oncologist. European Journal of Cancer, 50(3), 267-276. 11. Kuderer, N. M., et al. (2007). The Impact of Primary Prophylaxis with Granulocyte Colony-Stimulating Factor on Febrile Neutropenia and Mortality in Adult Cancer Patients Receiving Chemotherapy: A Systematic Review. Journal of Clinical Oncology, 25(21), 3158-3167. 12. Jones, L. W., et al. (2009). Cardiotoxicity of Cancer Therapy. Journal of the American College of Cardiology, 53(24), 2231-2242. 13. Seretny, M., et al. (2014). Incidence, Prevalence, and Predictors of Chemotherapy-Induced Peripheral Neuropathy: A Systematic Review and Meta-Analysis. Pain, 155(12), 2461-2470. 14. Ahles, T. A., & Root, J. C. (2018). Cognitive Effects of Cancer and Cancer Treatments. Annual Review of Clinical Psychology, 14(1), 425-451. 15. Batchelor, D. (2001). Hair and Cancer Chemotherapy: Consequences and Nursing Care—A Literature Study. European Journal of Cancer Care, 10(3), 147-163. 16. Bentzen, S. M., et al. (2010). Radiotherapy-Related Toxicity in Breast Cancer: A Retrospective Multicenter Study. International Journal of Radiation Oncology, Biology, Physics, 77(2), 324-330. 17. McGale, P., et al. (2011). Incidence of Heart Disease in 35,000 Women Treated with Radiotherapy for Breast Cancer in Denmark and Sweden. Radiotherapy and Oncology, 100(2), 167-175. 18. Buchan, J., et al. (2016). The Impact of Combined Modality Therapy on Lymphedema Risk in Breast Cancer Patients. Journal of Clinical Oncology, 34(3), 1116-1123. 19. Chan, R. J., et al. (2014). Topical Agents and Dressing for Radiation-Induced Skin Reactions in Breast Cancer Patients: Systematic Review and Meta-Analysis. British Journal of Cancer, 110(3), 42-50. 20. Bennett, M. I., et al. (2019). Gabapentin for Neuropathic Pain: Systematic Review and Meta-Analysis. BMJ, 354(i3686). 21. Liss, A. L., et al. (2017). Deep Inspiration Breath Hold: A Technique to Reduce Heart Dose in Breast Cancer Patients Receiving Radiation Therapy. Radiation Oncology, 12(1), 32-39. 22. Soran, A., et al. (2014). Breast Cancer-Related Lymphedema: What are the Significant Predictors and How They Affect the Severity of Lymphedema? Journal of Clinical Oncology, 32(8), 391-399. 23. Smith, T. J., et al. (2006). Update of Recommendations for the Use of White Blood Cell Growth Factors: An Evidence-Based Clinical Practice Guideline. Journal of Clinical Oncology, 24(19), 3187-3205. 24. Hershman, D. L., et al. (2014). Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline. Journal of Clinical Oncology, 32(18), 1941-1967.